Log In
Print
BCIQ
Print
Print this Print this
 

Bedaquiline (Sirturo) (TMC207) (formerly R207910)

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionDiarylquinoline (DARQ) antibiotic
Molecular Target Mycobacterial F1F0-ATP synthase
Mechanism of Action 
Latest Stage of DevelopmentApproved
IndicationTuberculosis
Partner

Global Alliance for TB Drug Development
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today